| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.20251 |
| P698 | PubMed publication ID | 15349870 |
| P50 | author | Nobutaka Hattori | Q64780524 |
| Yoshikuni Mizuno | Q64858705 | ||
| H Yoshino | Q67217957 | ||
| Hiroyuki Tomiyama | Q87283574 | ||
| Shuichi Asakawa | Q113063247 | ||
| P2093 | author name string | Nobuyoshi Shimizu | |
| Tatsushi Toda | |||
| Susumu Kobayashi | |||
| Raymond L Rosales | |||
| Masato Asahina | |||
| Kenichi Sato | |||
| Chin-Song Lu | |||
| Yasuhiro Yamamura | |||
| Sharon Hassin-Baer | |||
| Arlene R Ng | |||
| Yuanzhe Li | |||
| Yasuko Hatano | |||
| P2860 | cites work | DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. | Q51051455 |
| P433 | issue | 3 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| parkinsonian syndrome | Q1531991 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 424-427 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Novel PINK1 mutations in early-onset parkinsonism | |
| P478 | volume | 56 |
| Q40262236 | Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress |
| Q33315729 | Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2 |
| Q46441393 | Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease |
| Q33255660 | Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila |
| Q64782437 | Are we listening to everything the PARK genes are telling us? |
| Q24319830 | Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease |
| Q24307730 | Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1) |
| Q36488715 | Biology of mitochondria in neurodegenerative diseases |
| Q21245635 | Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease |
| Q93361066 | Cardiac-specific research platforms engender novel insights into mitochondrial dynamism |
| Q28384389 | Ceramide induced mitophagy and tumor suppression |
| Q36636038 | Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila |
| Q40011287 | Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation |
| Q36227376 | Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations |
| Q36752464 | Congenital disease SNPs target lineage specific structural elements in protein kinases |
| Q37767600 | Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis |
| Q36854642 | Deciphering the role of heterozygous mutations in genes associated with parkinsonism |
| Q89663725 | Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination |
| Q36385121 | Differential submitochondrial localization of PINK1 as a molecular switch for mediating distinct mitochondrial signaling pathways |
| Q45859017 | Distribution of PINK1 and LRRK2 in rat and mouse brain |
| Q24813326 | GBA server: EST-based digital gene expression profiling |
| Q33346009 | Genes associated with Parkinson syndrome |
| Q92035991 | Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study |
| Q82029352 | Genetic aspects of Parkinson's disease |
| Q22252904 | Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update |
| Q37921115 | Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson's disease |
| Q44698182 | Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications |
| Q38233866 | Genetics and genomics of Parkinson's disease |
| Q37037053 | Genetics of Parkinson disease |
| Q36423921 | Genetics of Parkinson disease: paradigm shifts and future prospects. |
| Q58269122 | Genetics of Parkinson's disease |
| Q40204484 | Genetics of Parkinson's disease and parkinsonism |
| Q81137333 | Genetics of parkinsonism |
| Q38706319 | HILAQ: A Novel Strategy for Newly Synthesized Protein Quantification |
| Q57419073 | Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients |
| Q33945927 | Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells |
| Q64253990 | Identification of Differentially Expressed Genes and Long Noncoding RNAs Associated with Parkinson's Disease |
| Q24300657 | Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen |
| Q39849125 | Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects |
| Q64763010 | Impact of gene mutation in the development of Parkinson's disease |
| Q28513036 | Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice |
| Q40088295 | In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites |
| Q64069696 | Integrated Analysis of Whole Exome Sequencing and Copy Number Evaluation in Parkinson's Disease |
| Q38772904 | Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease |
| Q54696016 | Is there a pathogenic role for mitochondria in Parkinson's disease? |
| Q35126377 | Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing |
| Q37882589 | Milestones in PD genetics |
| Q37037953 | Mitochondria in the aetiology and pathogenesis of Parkinson's disease |
| Q82029436 | Mitochondria in the etiology of Parkinson's disease |
| Q47147993 | Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease |
| Q53453128 | Mitochondrial Dysfunction in Parkinson's Disease. |
| Q34502221 | Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases |
| Q42560902 | Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function |
| Q37891820 | Mitochondrial contribution to Parkinson's disease pathogenesis |
| Q80228162 | Mitochondrial dysfunction in Parkinson's disease |
| Q48742196 | Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism |
| Q37954223 | Mitochondrial pathology in Parkinson's disease |
| Q30573776 | Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice |
| Q37561699 | Molecular pathogenesis of Parkinson disease: insights from genetic studies |
| Q39891449 | Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux |
| Q82852102 | Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism |
| Q24299939 | Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability |
| Q38268886 | Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression |
| Q35920094 | PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism |
| Q64779288 | PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons |
| Q33412371 | PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease |
| Q24299149 | PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy |
| Q36227281 | PINK1 mutation heterozygosity and the risk of Parkinson's disease |
| Q46932243 | PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies |
| Q24312106 | PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1 |
| Q50279934 | PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism |
| Q38946190 | Parkin and mitophagy in cancer. |
| Q39416222 | Parkinson's disease: genetics and beyond |
| Q36516918 | Parkinson's disease: the genetics of a heterogeneous disorder |
| Q36770206 | Pathogenic mutations in Parkinson disease |
| Q33799876 | Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. |
| Q24339508 | Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease |
| Q36226918 | Population genetic approaches to neurological disease: Parkinson's disease as an example |
| Q37143657 | Progress in the pathogenesis and genetics of Parkinson's disease |
| Q36449306 | Recessive Parkinson's disease |
| Q36595645 | Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease |
| Q37781565 | Regulation of autophagy by ROS: physiology and pathology |
| Q79805436 | Role of mitochondrial dysfunction in Parkinson's disease: Implications for treatment |
| Q37951338 | Role of p53 in neurodegenerative diseases |
| Q33393439 | Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism |
| Q38041529 | Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease |
| Q37299619 | Targeting the progression of Parkinson's disease. |
| Q38769351 | The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity |
| Q30273994 | The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons |
| Q34604083 | The genetics of Parkinson disease |
| Q41525066 | The impact of genetic research on our understanding of Parkinson's disease |
| Q38006955 | The many faces of mitochondrial autophagy: making sense of contrasting observations in recent research |
| Q40074115 | The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. |
| Q93193246 | The role of monogenic genes in idiopathic Parkinson's disease |
| Q37466094 | Tickled PINK1: mitochondrial homeostasis and autophagy in recessive Parkinsonism. |
| Q34890228 | Transgenic animal models of neurodegeneration based on human genetic studies. |
| Q36861432 | Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration |
| Q22252835 | Transgenic rodent models of Parkinson’s disease |
| Q26770342 | Ubiquitin phosphorylation in Parkinson's disease: Implications for pathogenesis and treatment |
| Q35911798 | Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration |
| Q34429308 | Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression. |
| Q46579323 | iPS cells in the study of PD molecular pathogenesis |
| Q38077665 | α-Synuclein and mitochondrial dysfunction in Parkinson's disease |
Search more.